In the present study, we aimed to evaluate the combined efficacy of ERBB1 and c-MET targeted therapies in vitro in brain metastatic ERBB2+ cell lines and in an organoid model, and in vivo in a novel orthotopic model of spontaneous BC metastasis. The gene discussed is MET; the disease is breast cancer.